✦ LIBER ✦

Changes in Lipoprotein Particle Number with Ezetimibe/Simvastatin Co-administered with Extended-Release Niacin in Patients with Type II Hyperlipidemia†

✍ Scribed by Ngoc-Anh Le; Ran Jin; Andrew M. Tershakovec; David R. Neff; Joanne E. Tomassini; James Otvos; Peter Wilson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Changes in Lipoprotein-associated Phosph

✍ Ngoc-Anh Le; Monica Farkas-Epperson; Ran Jin; Andrew M. Tershakovec; David R. Ne 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 99 KB

EFFICACY AND SAFETY OF EZETIMIBE/SIMVAST

✍ FAZIO, S; BROWN, B; GUYTON, J; POLIS, A; TOMASSINI, J; TERSHAKOVEC, A 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Lipid-Altering Efficacy and Safety of Ez

✍ John R. Guyton; B. Greg Brown; Sergio Fazio; Adam Polis; Joanne E. Tomassini; An 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 463 KB

Long-term Effect of Combination Ezetimib

✍ Joanne E. Tomassini; Sergio Fazio; John Guyton; Andrew Tershakovec 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 78 KB

LIPID-ALTERING EFFICACY AND SAFETY PROFI

✍ Farnier, M.; Ose, L.; Gleim, G.; Liu, N.; Thompson-Bell, S.; Beckey, K.; Johnson 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 198 KB

PO23-788 EFFECTS OF CO-ADMINISTERED EZET

✍ Farnier, M.; Perevozskaya, I.T.; Taggart, W.V.; Kush, D.; Mitchel, Y.B. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 100 KB